Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-26-150470
Filing Date
2026-04-10
Accepted
2026-04-10 09:25:54
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d17525d424b3.htm 424B3 82861
2 GRAPHIC g17525g16a26.jpg GRAPHIC 32146
  Complete submission text file 0001193125-26-150470.txt   121873
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-294843 | Film No.: 26853370
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)